Business Insider

PrEP Biopharm Limited announces Successful Completion of PrEP-001 Toxicology Study enabling Phase 2b Field Study of PrEP-001 Against All Respiratory Viruses

LONDON, Dec. 16, 2020 /PRNewswire/ -- PrEP Biopharm Limited, a private drug company developing treatments for respiratory infectious diseases, announced that it has successfully completed a 12-week ...
Healio

Study supports testing HIV PrEP users for STIs at 6 months instead of 3

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Six-month STI testing for HIV PrEP users is comparable ...
Hosted on MSN

Study flags gaps in PrEP use among youth at risk for HIV

U.S. adolescents and young adults at risk of HIV aren't getting the preexposure prophylaxis (PrEP) prescriptions they need, according to a national analysis of prescription data on over 100,000 youth.
Monthly Prescribing Reference

Study: 3-Day PrEP Effective in Reducing HIV Risk in MSM

A pre-exposure prophylaxis (PrEP) regimen of tenofovir/emtricitabine taken before and after sex reduced the risk of HIV among men who have sex with men (MSM) by an average of 86%, according to results ...